Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Antioxidants prevent oxidative stress that possibly causes neuronal loss in Alzheimer’s disease (AD). We examined whether high plasma levels of the antioxidant vitamins A and E were associated with lower prevalence of AD or cognitive decline (CD). We performed a cross-sectional study within the Rotterdam Study. In an univariate model, higher levels of vitamins A and E were significantly associated with lower prevalence of AD. However, when additional adjustments were made for important confounders, such as age, gender and total cholesterol, the relation substantially weakened – odds ratios per standard deviation increase were 0.87 (95% CI 0.64–1.19) for vitamin A and 0.94 (95% CI 0.60–1.48) for vitamin E. Antioxidants were not related to CD in non-demented subjects. Our findings suggest no association between plasma levels of vitamin A and E and AD or CD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas 3 found no significant association [181,191,202].”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [191]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · cited 1×
“Screen positives (MMSE score of 0) were further cognitively tested using the Cambridge Examination for Mental Disorders of the Elderly [”
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158
Determinants of disease and disability in the elderly: The Rotterdam elderly study
Hofman, A., Grobbee, D. E., De Jong, P. T. V. M., & Van den Ouweland, F. A. (1991) · European Journal of Epidemiology · doi:10.1007/bf00145007 · Cited by 1,129
Self-citationDietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Self-citationCopeland, J. R. M., Kelleher, M. J., Kellett, J. M., Gourlay, A. J., Gurland, B. J., Fleiss, J. L., & Sharpe, L. (1976) · Psychological Medicine · doi:10.1017/s0033291700015889 · Cited by 703
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · cited 1×
“For instance, it has been found that DNA and membrane lipids are damaged by oxidation. This oxidation may lead to neuronal cell loss, an important feature in Alzheimer brains. Because antioxidants can counteract oxidation and thus prevent neuronal cell death, high levels may lower the risk of AD.Previously, we and oth…”
Incidence and Risk of Dementia: The Rotterdam study
Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455 · cited 1×
“The Rotterdam Study was performed among inhabitants of a district of Rotterdam, the Netherlands, who were aged 55 years and over. The medical ethics committee of the Erasmus University Rotterdam approved the study, and written informed consent was obtained from all 7,983 participants.The baseline, first follow-up and…”
Self-citationCognitive Decline Is Associated with Systemic Oxidative Stress: The EVA Study
Berr, C., Balansard, B., Arnaud, J., Roussel, A., Alpérovitch, A., & EVA Study Group (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02603.x · Cited by 281
Lipid Peroxidation and Free Radical Scavengers in Alzheimer’s Disease
Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., & Cuny, G. (1989) · Gerontology · doi:10.1159/000213037 · Cited by 250
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease
Foy, C. J. (1999) · QJM · doi:10.1093/qjmed/92.1.39 · Cited by 235
Bourdel-Marchasson, I. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.235 · Cited by 215
Plasma Concentrations of Vitamins A and E and Carotenoids in Alzheimer's Disease
ZAMAN, Z., ROCHE, S., FIELDEN, P., FROST, P. G., NIRIELLA, D. C., & CAYLEY, A. C. D. (1992) · Age and Ageing · doi:10.1093/ageing/21.2.91 · Cited by 202
Increased lipoprotein oxidation in alzheimer’s disease
Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H.-J., Mann, U., Müller-Thomsen, T., & Beisiegel, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00247-6 · Cited by 199
Low plasma vitamin C in Alzheimer patients despite an adequate diet
Rivi�re, S., Birlouez-Aragon, I., Nourhash�mi, F., & Vellas, B. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(1998110)13:11<749::aid-gps860>3.0.co;2-t · Cited by 163
Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia
Sinclair, A. J., Bayer, A. J., Johnston, J., Warner, C., & Maxwell, S. R. J. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(1998120)13:12<840::aid-gps877>3.0.co;2-r · Cited by 143
van Gent, C. M., van der Voort, H. A., Bruyn, A. M. D., & Klein, F. (1977) · Clinica Chimica Acta · doi:10.1016/0009-8981(77)90195-4 · Cited by 131
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease
Jiménez‐Jiménez, F. J., de Bustos, F., Molina, J. A., Benito‐León, J., Tallón-Barranco, A., Gasalla, T., Pareja, M. O., Guillamón, F., Rubio‐Terres, C., Arenas, J., et al. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291887 · Cited by 112
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease
Ahlskog, J. E., Uitti, R. J., Low, P. A., Tyce, G. M., Nickander, K. K., Petersen, R. C., & Kokmen, E. (1995) · Movement Disorders · doi:10.1002/mds.870100507 · Cited by 91
Catignani, G. L. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(86)23025-6 · Cited by 84
Biochemical Indicators of Dietary Intake
Willett, W. (1998) · Nutritional Epidemiology · doi:10.1093/acprof:oso/9780195122978.003.09 · Cited by 76
Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.
Fernandes, M. A., Proenca, M. T., Nogueira, A. J., Grazina, M. M., Oliveira, L. M., Fernandes, A. I., Santiago, B., Santana, I., & Oliveira, C. R. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.4.2.179 · Cited by 48
Stump, D. D., Roth, E. F., & Gilbert, H. S. (1984) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80901-9 · Cited by 45
Kay, D. W. K., Dewey, M. E., McKeith, I. G., O'Cuill, M., McCracken, C., Fairbairn, A. F., Harrison, R., Illing, J. C., & Hrisos, S. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(1998120)13:12<852::aid-gps882>3.0.co;2-y · Cited by 16
Carotenaemia in Alzheimer's disease.
Singh, S., Mulley, G. P., & Losowsky, M. S. (1988) · BMJ · doi:10.1136/bmj.297.6646.458 · Cited by 14
Research works printed but not linked: 2
- 10.1002%2F%28SICI%291099-1166%281998110%2913%3A11%3C749%3A%3AAID-GPS860%3E3.3.CO%3B2-K · doi:10.1002/(sici)1099-1166(1998110)13:11<749::aid-gps860>3.3.co;2-k
- 10.1002%2F%28SICI%291099-1166%281998120%2913%3A12%3C840%3A%3AAID-GPS877%3E3.3.CO%3B2-I · doi:10.1002/(sici)1099-1166(1998120)13:12<840::aid-gps877>3.3.co;2-i
Cited by
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory
Massaad, C. A., & Klann, E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3208 · Cited by 635
“However, when adjustments were made with respect to age, gender, and total cholesterol, the correlation weakened, and it was concluded that there was no association between plasma levels of vitamin A and E and cognitive decline (122).”
BackgroundResultRomán, G. C., Jackson, R. E., Gadhia, R., Román, A. N., & Reis, J. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.08.005 · Cited by 421
Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis
Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., & Stijnen, T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1771 · Cited by 311
Denis, I., Potier, B., Vancassel, S., Heberden, C., & Lavialle, M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.01.007 · Cited by 150
Metadata
- Authors
- Engelhart, M. J., Ruitenberg, A., Meijer, J., Kiliaan, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B.
- Affiliations
- Erasmus MC (NL)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 19
- Issue
- 2-3
- Pages
- 134-139
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- OpenAlex
- W2149688229
- Cited by
- 52
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 5
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- Alzheimer's disease, cognitive decline, vitamin A, vitamin E, antioxidants, oxidative stress, dementia risk, Rotterdam Study
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Antioxidants, Cognition Disorders, Cross-Sectional Studies, Female, Humans, Male, Mental Status Schedule, Netherlands, Population Surveillance, Prospective Studies, Statistics as Topic, Vitamin A, Vitamin E, Cohort Studies, Geriatric Assessment, Logistic Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.